Dental Precautions for Patients Taking Fosamax (Alendronate)
Patients taking Fosamax (alendronate) should have a comprehensive dental examination before starting therapy and maintain regular dental follow-ups at least every 6 months to minimize the risk of medication-related osteonecrosis of the jaw (MRONJ). 1
Pre-Treatment Dental Assessment
- A comprehensive dental evaluation of both hard and soft tissues is recommended before starting bisphosphonate treatment 1
- Complete any necessary invasive dental procedures before initiating bisphosphonate therapy 1
- Eliminate potential sources of dental trauma (e.g., ill-fitting prostheses, fractured teeth) 1
- Establish good oral hygiene practices before starting treatment 1
Oral Hygiene Recommendations During Treatment
Daily Oral Care
- Use a small, ultra-soft-headed, rounded-end bristle toothbrush 1
- Brush teeth twice daily with fluoride-containing, non-foaming toothpaste 1
- Floss at least once daily; waxed floss may minimize trauma to gums 1
- If flossing causes bleeding that doesn't stop within 2 minutes, consult your healthcare provider 1
Denture Care
- Remove dentures before performing oral care 1
- Brush dentures with toothpaste and rinse with water 1
- Remove dentures for extended periods (at least 8 hours daily) 1
- Soak dentures in antimicrobial solution before reinsertion 1
Mouth Rinses
- Rinse with alcohol-free mouthwash or a bland rinse (1 teaspoon salt, 1 teaspoon baking soda in 4 cups of water) 1
- Avoid commercial mouthwashes with alcohol or astringent properties 1
Precautions for Dental Procedures
Invasive Dental Procedures
- Elective surgical dental procedures are generally contraindicated during bisphosphonate therapy 1
- When dental procedures are necessary for oral function or to control disease:
Extraction Protocols
If tooth extraction is unavoidable:
- Antibiotic coverage is recommended 2
- Nontraumatic avulsion and closure by secondary intention appears to be safe and comfortable for patients 2
Monitoring and Follow-Up
- Regular dental check-ups at least every 6 months 1
- Inspect oral mucosa daily for any abnormalities 1
- Report any symptoms such as pain, swelling, numbness, or exposed bone promptly 1
- If signs of MRONJ develop, immediate referral to a specialist is necessary 1
Special Considerations
Drug Holiday
- The decision to temporarily discontinue bisphosphonate therapy before dental procedures is controversial 1
- Some experts suggest stopping treatment 2 months prior to oral surgery and delaying restart until osseous healing has occurred 1
- Others note that a short break may have no effect since bisphosphonates remain in bone for years 1
- This decision should be made in consultation between the dental specialist and the prescribing physician 1
Risk Factors for MRONJ
- The risk increases with frequency, dose, and duration of bisphosphonate treatment 1
- Risk is lower with weekly oral dosing (as in osteoporosis treatment) compared to higher doses used for cancer 1
- Reported incidence of MRONJ with oral bisphosphonates for osteoporosis is relatively low (0.1-0.6%) 1
Patient Education
- Understand the importance of maintaining excellent oral hygiene 1
- Recognize and report early signs of potential complications 1
- Avoid tobacco and limit alcohol consumption 1
- Ensure adequate calcium and vitamin D intake, but take calcium supplements at least 2 hours apart from oral bisphosphonates 1
By following these precautions, patients on Fosamax can minimize their risk of developing serious dental complications while benefiting from the medication's protective effects against fractures.